Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
Cell Stress & Chaperones|March 12, 2010
Febrile range temperature represses TNF-alpha gene expression in LPS-stimulated macrophages by selectively blocking recruitment of Sp1 to the TNF-alpha promoterZachary A Cooper, Ishwar S Singh, Jeffrey D HasdayCancer Discovery|November 15, 2014
Universes collide: combining immunotherapy with targeted therapy for cancerJennifer A Wargo, Zachary A Cooper, Keith T FlahertyCancer Journal (Sudbury, Mass.)|April 26, 2016
Targeted Therapies Combined With Immune Checkpoint TherapyPeter A Prieto, Alexandre Reuben, Zachary A Cooper, et al.Immunotargets and Therapy|July 30, 2016
Update on use of aldesleukin for treatment of high-risk metastatic melanomaRodabe N Amaria, Alexandre Reuben, Zachary A Cooper, et al.Journal of Pigmentary Disorders|December 19, 2017
RAF Inhibitor Therapy Promotes Melanocytic Antigen Expression and Enhanced Anti-Tumor Immunity in MelanomaAlexandre Reuben, Rodabe N Amaria, Zachary A Cooper, et al.Oncoimmunology|June 14, 2013
Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanomaZachary A Cooper, Dennie T Frederick, Zain Ahmed, et al.Oncoimmunology|May 6, 2015
Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanomaZachary A Cooper, Alexandre Reuben, Rodabe N Amaria, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2015
Does It MEK a Difference? Understanding Immune Effects of Targeted TherapyZachary A Cooper, Alexandre Reuben, Jacob Austin-Breneman, et al.Cancer Treatment and Research|November 26, 2015
Novel Treatments in Development for MelanomaChantale Bernatchez, Zachary A Cooper, Jennifer A Wargo, et al.International Journal of Biochemistry and Molecular Biology|April 18, 2012
Rapamycin induces the anti-apoptotic protein survivin in neuroblastomaAyman Samkari, Zachary A Cooper, Michael P Holloway, et al.Pageof 9